Amersham plc

Description

Amersham is a world leader in medical diagnostics and in life sciences. Our company is focused on enabling molecular medicine, working through three main business areas in diagnostic imaging, protein separations and discovery systems. Headquartered in the UK, we employ over 10,000 people worldwide and had sales of £1.62 billion ($2.54 billion) in 2002. Amersham shares (AHM) are traded on the London, New York and Oslo stock exchanges and we are part of the FTSE index of Britain's 100 largest public companies.Our strategy is to build our position as a leading provider of products and technologies enabling disease to be better understood, diagnosed sooner and treated more effectively, based upon a growing understanding of disease at the molecular level.Amersham is organised in two businesses, Amersham Health (medical diagnostics and therapy products) and Amersham Biosciences (discovery systems and protein separations). The company was formed in 1997 from the mergers of Amersham International (UK), Pharmacia Biotech (Sweden) and Nycomed (Norway). Sir William Castell is Amersham's Chief Executive.

Companies nearby